This study investigates the effects of gamma therapy stimulation on cognitive function in patients with Alzheimer's disease (AD). The therapy utilizes auditory and visual stimulation to enhance gamma oscillations, which are crucial for cognition and memory.
Begin with a patient diagnosed with Alzheimer’s disease, wearing a gamma therapy stimulation device.
The device consists of an eye-set and headphones.
Using the controller, activate the device to deliver auditory and visual stimulation.
The visual component emits flickering light at a gamma frequency, while the auditory component produces synchronized sound pulses.
Gamma oscillations are brain waves generated by synchronized neuronal firing, crucial for cognition and memory.
In AD, these oscillations are disrupted, leading to cognitive decline.
Sensory-evoked gamma oscillations activate interneurons, which intermittently inhibit excitatory pyramidal neurons, promoting synchronized firing.
This synchronization strengthens synaptic connections by increasing excitatory AMPA receptor density at the postsynaptic terminal, which is essential for memory retention.
The stimulation also enhances cerebral blood flow, improving oxygen and nutrient supply, thereby supporting better cognitive function.
Additionally, the stimulation activates microglia and astrocytes, aiding amyloid-beta clearance and thereby slowing AD progression.
繁體中文
